NCT04771962

Brief Summary

Desflurane and Sevoflurane are one of the modern inhalational anaesthetic agents currently in use in anaesthetic practice. The properties of desflurane that has low blood gas solubility coefficient of 0.47 compared to sevoflurane (0.68) made it more advantageous when used with supraglottic airway in maintaining general anaesthesia in paediatrics . It ensures rapid onset and offset of anaesthesia. Rapid recovery profiles especially among pediatric populations is to ensure less complications associated with prolonged recovery of anaesthesia upon emergence from anaesthesia. Nevertherless, desflurane has its drawback which is it can cause airway irritability related to its pungency. Hence, it is not used as an induction anaesthetic agent in paediatrics. This study was done to evaluate the effectiveness of desflurane in comparison to sevoflurane in maintaining spontaneous general anaesthesia in paediatrics population using Ambu AuraGain .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jan 2020

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 25, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

2 years

First QC Date

November 4, 2020

Last Update Submit

September 27, 2023

Conditions

Keywords

paediatricsspontaneous general anaesthesia

Outcome Measures

Primary Outcomes (3)

  • To compare the blood pressure intraoperatively between desflurane and sevoflurane.

    by measuring the blood pressure

    up to 18 months

  • To compare the heart rate intraoperatively between desflurane and sevoflurane.

    by measuring the heart rate

    up to 18 months

  • To compare the mean arterial pressure intraoperatively between desflurane and sevoflurane.

    by measuring the mean arterial pressure

    up to 18 months

Secondary Outcomes (2)

  • To compare the emergence time ( interval from gas being off to patient awake).

    up to 18 months

  • To compare the respiratory events intraoperative and post operative

    up to 18 months

Study Arms (2)

DESFLURANE

EXPERIMENTAL

desflurane group- this group of patients will be induced with sevoflurane and maintained with desflurane during spontaneous general anaesthesia

Drug: DESFLURANE AND SEVOFLURANE

SEVOFLURANE

ACTIVE COMPARATOR

the controlled group.patients will be induced and maintained with sevoflurane through out spontaneous general anaesthesia.

Drug: DESFLURANE AND SEVOFLURANE

Interventions

COMPARING THE EFFICACY IN MAINTAINANCE OF SPONTANEOUS GENERAL ANAESTHESIA USING AMBU AURA GAIN IN PEDIATRIC PATIENTS

Also known as: Suprane and Sevoflurane
DESFLURANESEVOFLURANE

Eligibility Criteria

Age3 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged: 3 years to 12 years old.
  • ASA (American Society of Anesthesiologist) I
  • BMI (body mass index) less than 95 centile according to age, sex, height
  • Preoperative assessment shows low risk of aspiration and no features of difficult intubation.
  • No history of difficult intubation or history of admission to ICU for airway complication.
  • Operation duration less or equal 2 hours using AmbuAuraGain.

You may not qualify if:

  • Parent refusal for study participation to give informed consent.
  • Patients who had an upper respiratory tract infection (URTI) within previous 2 weeks or any respiratory disease ( bronchial asthma, hyperactive airway,sleep apnea, chronic lung disease)
  • Known susceptibility to malignant hyperthermia (MH)
  • History of moderate to severe hepatic dysfunction following anaesthesia with desflurane not otherwise explained.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Science Malaysia Hospital

Kubang Kerian, Kelantan, 16150, Malaysia

Location

Related Publications (10)

  • Lerman J, Hammer GB, Verghese S, Ehlers M, Khalil SN, Betts E, Trillo R, Deutsch J; MAPS Investigators Group. Airway responses to desflurane during maintenance of anesthesia and recovery in children with laryngeal mask airways. Paediatr Anaesth. 2010 Jun;20(6):495-505. doi: 10.1111/j.1460-9592.2010.03305.x. Epub 2010 Apr 23.

    PMID: 20456065BACKGROUND
  • Akhtam A. Shoukry, Ayman Abd Laltif,Amr Abd Fattah, Ibrahim Abd Ghani, Mohamed Serag. Isoflurane versus desflurane : hemodynamic parametres and recovery charecteristics:a comparative study.Ain Shams Journal of Anaesthesiology 2016,9:45-51

    BACKGROUND
  • Demirbilek S, Togal T, Cicek M, Aslan U, Sizanli E, Ersoy MO. Effects of fentanyl on the incidence of emergence agitation in children receiving desflurane or sevoflurane anaesthesia. Eur J Anaesthesiol. 2004 Jul;21(7):538-42. doi: 10.1017/s0265021504007069.

    PMID: 15318465BACKGROUND
  • White PF, Tang J, Wender RH, Yumul R, Stokes OJ, Sloninsky A, Naruse R, Kariger R, Norel E, Mandel S, Webb T, Zaentz A. Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. Anesth Analg. 2009 Aug;109(2):387-93. doi: 10.1213/ane.0b013e3181adc21a.

    PMID: 19608808BACKGROUND
  • Kim EH, Song IK, Lee JH, Kim HS, Kim HC, Yoon SH, Jang YE, Kim JT. Desflurane versus sevoflurane in pediatric anesthesia with a laryngeal mask airway: A randomized controlled trial. Medicine (Baltimore). 2017 Sep;96(35):e7977. doi: 10.1097/MD.0000000000007977.

    PMID: 28858134BACKGROUND
  • Sethi S, Ghai B, Ram J, Wig J. Postoperative emergence delirium in pediatric patients undergoing cataract surgery--a comparison of desflurane and sevoflurane. Paediatr Anaesth. 2013 Dec;23(12):1131-7. doi: 10.1111/pan.12260. Epub 2013 Sep 19.

    PMID: 24102666BACKGROUND
  • Davis PJ, Cohen IT, McGowan FX Jr, Latta K. Recovery characteristics of desflurane versus halothane for maintenance of anesthesia in pediatric ambulatory patients. Anesthesiology. 1994 Feb;80(2):298-302. doi: 10.1097/00000542-199402000-00009.

    PMID: 8311312BACKGROUND
  • Jindal R, Kumra VP, Narani KK, Sood J. Comparison of maintenance and emergence characteristics after desflurane or sevoflurane in outpatient anaesthesia. Indian J Anaesth. 2011 Jan;55(1):36-42. doi: 10.4103/0019-5049.76604.

    PMID: 21431051BACKGROUND
  • Satyanarayana A, Aparanji K, Gopalakrishna K. Comparison of airway responses, haemodynamics and recovery using sevoflurane and desflurane via laryngeal mask airway in day care paediatric surgeries. J. Evid. Based Med. Healthc. 2017; 4(92), 5559-5563.

    BACKGROUND
  • Kotwani MB, Malde AD. Comparison of maintenance, emergence and recovery characteristics of sevoflurane and desflurane in pediatric ambulatory surgery. J Anaesthesiol Clin Pharmacol. 2017 Oct-Dec;33(4):503-508. doi: 10.4103/joacp.JOACP_194_16.

    PMID: 29416244BACKGROUND

MeSH Terms

Interventions

DesfluraneSevoflurane

Intervention Hierarchy (Ancestors)

Ethyl EthersEthersOrganic ChemicalsMethyl EthersHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Officials

  • Rhendra Hardy Mohamed Zaini

    University Sains Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant Anesthetist and lecturer

Study Record Dates

First Submitted

November 4, 2020

First Posted

February 25, 2021

Study Start

January 1, 2020

Primary Completion

December 15, 2021

Study Completion

December 31, 2021

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations